Everest Medicines raised $310M Series C venture round, led by Hillhouse Capital.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Private | — |
| Private Equity | — |
Jiashan SDICLEAD | Venture Capital | — |
Janchor PartnersLEAD | Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$310M
Top Valuation
-
Everest Medicines raised $310M in a Series C round.
The round was announced on 06/05/20.
The round was led by Hillhouse Capital, John Ho, Jiashan SDIC, RA Capital Management.